Literature DB >> 12498144

Percutaneous ultrasound-guided cholecystocentesis in dogs.

K Vörös1, Agnes Sterczer, F Manczur, T Gaál.   

Abstract

Percutaneous ultrasound-guided cholecystocentesis was performed on 13 healthy beagle dogs to determine whether percutaneous ultrasound-guided cholecystocentesis in the dog was a feasible and safe procedure. Clinical, laboratory and ultrasonographic examinations were done at 0 and 10 minutes, in the 2nd and 16th hour, and on the 7th day. They included a detailed physical examination of the mucous membranes, cardiorespiratory system and abdominal organs. Laboratory examinations of the blood consisted of a complete blood count, determination of packed cell volume (PCV), haemoglobin (Hb), total plasma protein (TPP), parameters of haemostasis including prothrombin time (PT), activated partial thromboplastin time (APTT), and enzyme activities reflecting hepatobiliary function, i.e. aspartate aminotransferase (AST), alanine aminotransferase (ALT), and gamma-glutamyltransferase (GGT). Ultrasonographic findings of the gallbladder (size, shape, wall, content) and appearance of the biliary tract and the surrounding cranial intraabdominal organs were also evaluated. Percutaneous ultrasound-guided cholecystocentesis was performed easily during the study, and dogs tolerated well the procedure performed without anaesthesia. All laboratory parameters of the blood remained within normal limits throughout the study. However, some follow-up values, i.e. PCV, TPP, APTT and ALT, demonstrated statistically significant differences when compared to baseline measurements, which might reflect the effect of 24-hour fasting before the experiment, as well as day-to-day metabolic fluctuations due to feeding and water supply during the study. There were no visible signs of bleeding from the liver, bile leakage from the gallbladder or accumulation of free peritoneal fluid during repeated ultrasonographic examinations. Percutaneous ultrasound-guided cholecystocentesis seems to be an important diagnostic procedure in canine gallbladder diseases and can be used safely and easily to gain gallbladder bile for diagnosis of bacterial cholecystitis or for investigating hepatobiliary function in the dog.

Entities:  

Mesh:

Year:  2002        PMID: 12498144     DOI: 10.1556/AVet.50.2002.4.2

Source DB:  PubMed          Journal:  Acta Vet Hung        ISSN: 0236-6290            Impact factor:   0.955


  6 in total

1.  Bacterial cholangiohepatitis in a dog.

Authors:  Eve Ramery; Stratos Papakonstantinou; Manuel Pinilla; Hester McAllister; Hanne Jahns; Barbara Gallagher; Peter J O'Brien
Journal:  Can Vet J       Date:  2012-04       Impact factor: 1.008

2.  Extrahepatic biliary duct obstruction secondary to duodenal foreign bodies in 2 dogs.

Authors:  Jasmine Gu; Sally Sukut; Koji Aoki; Lesley Zwicker
Journal:  Can Vet J       Date:  2019-09       Impact factor: 1.008

3.  Percutaneous Ultrasound-guided Cholecystocentesis and Bile Analysis for the Detection of Platynosomum spp.-Induced Cholangitis in Cats.

Authors:  L Köster; L Shell; O Illanes; C Lathroum; K Neuville; J Ketzis
Journal:  J Vet Intern Med       Date:  2016-04-05       Impact factor: 3.333

4.  Application of ultrasound-guided cholecystocentesis to the evaluation of the metabolite profiling in bile of dogs and cynomolgus monkeys.

Authors:  Elizabeth A Dierks; Chiuwa E Luk; Hong Cai; Jamus MacGuire; Maxine Fox; James Smalley; R Marc Fancher; Evan Janovitz; Kimberly Foster; Qin Sun
Journal:  Pharmacol Res Perspect       Date:  2019-05-27

5.  Chronic cholecystitis: Diagnostic and therapeutic insights from formerly bile-farmed Asiatic black bears (Ursus thibetanus).

Authors:  Szilvia K Kalogeropoulu; Emily J Lloyd; Hanna Rauch; Irene Redtenbacher; Michael Häfner; Iwan A Burgener; Johanna Painer-Gigler
Journal:  PLoS One       Date:  2022-03-03       Impact factor: 3.240

6.  Cytological Findings of 140 Bile Samples from Dogs and Cats and Associated Clinical Pathological Data.

Authors:  L M Peters; B Glanemann; O A Garden; B Szladovits
Journal:  J Vet Intern Med       Date:  2015-11-14       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.